<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2016-44-48</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-2168</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Остеопороз: оценка риска возникновения повторных малотравматичных переломов у женщин в постменопаузе</article-title><trans-title-group xml:lang="en"><trans-title>OSTEOPOROSIS: ASSESSMENT OF A RISK FOR RECURRENT LOW-TRAUMA FRACTURES IN POSTMENOPAUSAL WOMEN</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Добровольская</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dobrovolskaya</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва, 115522 Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><email xlink:type="simple">epid@irramn.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торопцова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Toroptsova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва, 115522 Москва, Каширское шоссе, 34А</p></bio><bio xml:lang="en"><p>34A, Kashirskoe Shosse, Moscow 115522</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ Научно-исследовательский институт ревматологии им. В.А. Насоновой</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.A. Nasonova Research Institute of Rheumatology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>23</day><month>03</month><year>2016</year></pub-date><volume>54</volume><issue>1</issue><fpage>44</fpage><lpage>48</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Добровольская О.В., Торопцова Н.В., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Добровольская О.В., Торопцова Н.В.</copyright-holder><copyright-holder xml:lang="en">Dobrovolskaya O.V., Toroptsova N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/2168">https://rsp.mediar-press.net/rsp/article/view/2168</self-uri><abstract><p>Цель исследования – оценить риск новых переломов в когорте женщин в постменопаузе, перенесших малотравматичный перелом, с использованием алгоритма FRAX® и сопоставить результат оценки с данными о переломах, произошедших в ходе проспективного наблюдения.</p><sec><title>Материал и методы</title><p>Материал и методы. В исследование включены 128 женщин (средний возраст 64,9±8,3 года) в постменопаузе, перенесших малотравматичные переломы пяти локализаций (бедро, предплечье, шейка плечевой кости, позвоночник и лодыжка). Оценка 10-летнего риска переломов была проведена с использованием алгоритма FRAX® как с учетом минеральной плотности кости (МПК), так и без нее. Регистрация новых остеопоротических переломов проводилась в течение трехлетнего проспективного наблюдения.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Средние показатели риска по алгоритму FRAX® для всех новых остеопоротических переломов и переломов бедра по группе в целом составили 18,0±5,6 и 3,7±3,7% (без учета МПК), 17,9±6,6 и 3,5±4,0% (с учетом МПК), р&gt;0,05. Реальная частота повторных переломов за 3 года составила 17,2%. У женщин, перенесших малотравматичные переломы проксимального отдела бедра, шейки плечевой кости и позвоночника, за 3 года частота повторных переломов составила 28,6; 25,0 и 22,8% соответственно, что превышало расчетный 10-летний риск переломов для данных локализаций. Наличие множественных малотравматичных переломов по сравнению с одним переломом в анамнезе увеличивало вероятность нового перелома в 3,63 раза среди женщин с высоким и в 9,43 раза – с низким расчетным показателем риска по FRAX®.</p></sec><sec><title>Заключение</title><p>Заключение. Трехлетнее проспективное наблюдение показало, что в алгоритме FRAX® имеется недооценка риска, связанного с наличием повторных переломов в анамнезе; кроме того, новые переломы достоверно чаще возникают у лиц, перенесших малотравматичные переломы в области проксимального отдела бедра, шейки плечевой кости и позвоночника.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to assess a risk for new fractures in a cohort of postmenopausal women who have sustained low-trauma fractures, by using the FRAX® algorithm, and to compare the assessments with data on the fractures have occurred during a prospective follow-up study.</p></sec><sec><title>Subjects and methods</title><p>Subjects and methods. The investigation enrolled 128 postmenopausal women (mean age, 64.9±8.3 years) who had sustained low-trauma fractures at five sites (the hip, forearm, humeral neck, vertebral column, and ankle). A ten-year fracture risk was assessed using the FRAX® algorithm with and without regard for bone mineral density (BMD). New osteoporotic fractures were recorded during a three-year prospective follow-up study.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The average FRAX® algorithm values for all new osteoporotic and hip fractures in the entire group were 18.0±5.6 and 3.7±3.7% (without consideration of BMD), 17.9±6.6 and 3.5±4.0% (with consideration of BMD) (p &gt; 0.05). The true incidence of recurrent fractures over 3 years was 17.2%. During 3 years, the incidence of recurrent fractures in the women who had sustained low-trauma fractures of the proximal hip, humeral neck, and spinal column was 28.6, 25.0, and 22.8%, respectively, which exceeded the estimated 10-year fracture risk for these sites. The history of multiple low-trauma fractures versus single one increased the risk for subsequent fractures by 3.63 and 9.43 times among women with high or low estimated FRAX risk rate, respectively.</p></sec><sec><title>Conclusion</title><p>Conclusion. The three-year prospective follow-up study has shown that the FRAX® algorithm underestimated the risk associated with the presence of recurrent fractures in the history; moreover, new fractures significantly more commonly occur in persons who have sustained low-trauma fractures in the proximal hip, humoral neck, and vertebral column.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>постменопауза</kwd><kwd>постменопаузальный остеопороз</kwd><kwd>остеопоротические переломы</kwd><kwd>FRAX®</kwd></kwd-group><kwd-group xml:lang="en"><kwd>postmenopause</kwd><kwd>postmenopausal osteoporosis</kwd><kwd>osteoporotic fractures</kwd><kwd>FRAX®</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Rubin KH, Friis-Holmberg T, Hermann AP, et al. Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. Bone Miner Res. 2013 Aug;28(8):1701-17. doi: 10.1002/jbmr.1956</mixed-citation><mixed-citation xml:lang="en">Rubin KH, Friis-Holmberg T, Hermann AP, et al. Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. Bone Miner Res. 2013 Aug;28(8):1701-17. doi: 10.1002/jbmr.1956</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kannis JA; on behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary health care level. Technical Report. Sheffield, UK: World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield; 2007.</mixed-citation><mixed-citation xml:lang="en">Kannis JA; on behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary health care level. Technical Report. Sheffield, UK: World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield; 2007.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kanis JA, Borgstrom F, de Laet C, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581-9. doi: 10.1007/s00198-004-1780-5</mixed-citation><mixed-citation xml:lang="en">Kanis JA, Borgstrom F, de Laet C, et al. Assessment of fracture risk. Osteoporos Int. 2005;16:581-9. doi: 10.1007/s00198-004-1780-5</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kannis JA, Johnell O, Oden A, et al. FRAX® и оценка риска перелома у мужчин и женщин в Великобритании. Остеопороз и остеопатии. 2008;2(2):38-44 [FRAX® and assessment of risk of fracture in men and women in the UK. Osteoporoz i osteopatii = Osteoporosis and osteopathy. 2008;2(2):38-44 (In Russ.)].</mixed-citation><mixed-citation xml:lang="en">Kannis JA, Johnell O, Oden A, et al. FRAX® и оценка риска перелома у мужчин и женщин в Великобритании. Остеопороз и остеопатии. 2008;2(2):38-44 [FRAX® and assessment of risk of fracture in men and women in the UK. Osteoporoz i osteopatii = Osteoporosis and osteopathy. 2008;2(2):38-44 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Donaldson MG, Palermo L, Ensrud KE, et al. Effect of alendronate for reducing fracture by FRAX® score and femoral neck bone mineral density: the Fracture Intervention Trial. J Bone Miner Res. 2012 Aug;27(8):1804-10. doi: 10.1002/jbmr.1625</mixed-citation><mixed-citation xml:lang="en">Donaldson MG, Palermo L, Ensrud KE, et al. Effect of alendronate for reducing fracture by FRAX® score and femoral neck bone mineral density: the Fracture Intervention Trial. J Bone Miner Res. 2012 Aug;27(8):1804-10. doi: 10.1002/jbmr.1625</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kim K, Svedbom A, Luo X, et al. Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX® algorithm. Osteoporos Int. 2014 Jan;25(1):325-37. doi: 10.1007/s00198-013-2521-4</mixed-citation><mixed-citation xml:lang="en">Kim K, Svedbom A, Luo X, et al. Comparative cost-effectiveness of bazedoxifene and raloxifene in the treatment of postmenopausal osteoporosis in Europe, using the FRAX® algorithm. Osteoporos Int. 2014 Jan;25(1):325-37. doi: 10.1007/s00198-013-2521-4</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fiore CE, Gaudio A. When the FRAX® test is applied to controlled clinical trials. Clin Cases Miner Bone Metab. 2012 Sep;9(3):135-7.</mixed-citation><mixed-citation xml:lang="en">Fiore CE, Gaudio A. When the FRAX® test is applied to controlled clinical trials. Clin Cases Miner Bone Metab. 2012 Sep;9(3):135-7.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Catalano A, Morabito N, Basile G, et al. Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. Clin Cases Miner Bone Metab. 2013 Sep;10(3):191-4.</mixed-citation><mixed-citation xml:lang="en">Catalano A, Morabito N, Basile G, et al. Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. Clin Cases Miner Bone Metab. 2013 Sep;10(3):191-4.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Pang WY, Inderjeeth CA. FRAX® without bone mineral density versus osteoporosis self-assessment screening tool as predictors of osteoporosis in primary screening of individuals aged 70 and older. J Am Geriatr Soc. 2014 Mar;62(3):442-6. doi: 10.1111/jgs.12696</mixed-citation><mixed-citation xml:lang="en">Pang WY, Inderjeeth CA. FRAX® without bone mineral density versus osteoporosis self-assessment screening tool as predictors of osteoporosis in primary screening of individuals aged 70 and older. J Am Geriatr Soc. 2014 Mar;62(3):442-6. doi: 10.1111/jgs.12696</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Crandall CJ, Larson J, Gourlay ML, et al. Osteoporosis screening in postmenopausal women 50-64 years-old: Comparison of U.S. preventive services task force strategy and two traditional strategies in the women's health initiative. J Bone Miner Res. 2014;29(7): 1661-6. doi: 10.1002/jbmr.2174</mixed-citation><mixed-citation xml:lang="en">Crandall CJ, Larson J, Gourlay ML, et al. Osteoporosis screening in postmenopausal women 50-64 years-old: Comparison of U.S. preventive services task force strategy and two traditional strategies in the women's health initiative. J Bone Miner Res. 2014;29(7): 1661-6. doi: 10.1002/jbmr.2174</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cheung E, Cheung CL, Kung AW, Tan KC. Possible FRAX®-based intervention thresholds for a cohort of Chinese postmenopausal women. Osteoporos Int. 2014 Mar;25(3):1017-23. doi: 10.1007/s00198-013-2553-9</mixed-citation><mixed-citation xml:lang="en">Cheung E, Cheung CL, Kung AW, Tan KC. Possible FRAX®-based intervention thresholds for a cohort of Chinese postmenopausal women. Osteoporos Int. 2014 Mar;25(3):1017-23. doi: 10.1007/s00198-013-2553-9</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Кирпикова МН. Дифференцированный подход к диагностике и лечению постменопаузального остеопороза. Дис. … докт. мед. наук. Иваново; 2011. 222 с. [Kirpikova MN. Differentsirovannyi podkhod k diagnostike i lecheniyu postmenopauzal'nogo osteoporoza. Dis. … dokt. med. nauk [Differentiated approach to the diagnosis and treatment of postmenopausal osteoporosis. Doct dis.]. Ivanovo; 2011. 222 p.].</mixed-citation><mixed-citation xml:lang="en">Кирпикова МН. Дифференцированный подход к диагностике и лечению постменопаузального остеопороза. Дис. … докт. мед. наук. Иваново; 2011. 222 с. [Kirpikova MN. Differentsirovannyi podkhod k diagnostike i lecheniyu postmenopauzal'nogo osteoporoza. Dis. … dokt. med. nauk [Differentiated approach to the diagnosis and treatment of postmenopausal osteoporosis. Doct dis.]. Ivanovo; 2011. 222 p.].</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Попов АА, Струнина МВ, Телющенко МВ. Оценка абсолютного риска переломов у пациентов с выявленным остеопорозом дистального отдела предплечья. Остеопороз и остеопатии. 2012:(3):3-6 [Popov AA, Strunina MV, Telyushchenko MV. Evaluation of absolute fracture risk in patients diagnosed with osteoporosis of the distal forearm. Osteoporoz i osteopatii = Osteoporosis and osteopathy. 2012:(3):3-6 (In Russ.)].</mixed-citation><mixed-citation xml:lang="en">Попов АА, Струнина МВ, Телющенко МВ. Оценка абсолютного риска переломов у пациентов с выявленным остеопорозом дистального отдела предплечья. Остеопороз и остеопатии. 2012:(3):3-6 [Popov AA, Strunina MV, Telyushchenko MV. Evaluation of absolute fracture risk in patients diagnosed with osteoporosis of the distal forearm. Osteoporoz i osteopatii = Osteoporosis and osteopathy. 2012:(3):3-6 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Никитинская ОА, Торопцова НВ. Социальная программа «Остеоскрининг Россия» в действии. Фарматека. 2012;(6):90-3 [Nikitinskaya OA, Toroptsova NV. Social program «Osteoskrining Russia» in action. Farmateka. 2012;(6):90-3 (In Russ.)].</mixed-citation><mixed-citation xml:lang="en">Никитинская ОА, Торопцова НВ. Социальная программа «Остеоскрининг Россия» в действии. Фарматека. 2012;(6):90-3 [Nikitinskaya OA, Toroptsova NV. Social program «Osteoskrining Russia» in action. Farmateka. 2012;(6):90-3 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Мешалкина ЛЮ. Сравнительная оценка десятилетней вероятности по шкале FRAX® и реальной частоты переломов у женщин пожилого возраста с остеопорозом. Клиническая геронтология. 2012;18(1-2):19-22 [Meshalkina LYu. Comparative evaluation of the ten-year probability scale FRAX® and the real incidence of fractures in elderly women with osteoporosis. Klinicheskaya gerontologiya. 2012;18(1-2):19-22 (In Russ.)].</mixed-citation><mixed-citation xml:lang="en">Мешалкина ЛЮ. Сравнительная оценка десятилетней вероятности по шкале FRAX® и реальной частоты переломов у женщин пожилого возраста с остеопорозом. Клиническая геронтология. 2012;18(1-2):19-22 [Meshalkina LYu. Comparative evaluation of the ten-year probability scale FRAX® and the real incidence of fractures in elderly women with osteoporosis. Klinicheskaya gerontologiya. 2012;18(1-2):19-22 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Azagra R, Roca G, Encabo G, et al. FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort. BMC Musculoskelet Disord. 2012 Oct 22;13:204. doi: 10.1186/1471-2474-13-204</mixed-citation><mixed-citation xml:lang="en">Azagra R, Roca G, Encabo G, et al. FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort. BMC Musculoskelet Disord. 2012 Oct 22;13:204. doi: 10.1186/1471-2474-13-204</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sornay-Rendu E, Munoz F, Delmas PD, Chapurlat RD. The FRAX® tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort? J Bone Miner Res. 2010 Oct;25(10):2101-7. doi: 10.1002/jbmr.106</mixed-citation><mixed-citation xml:lang="en">Sornay-Rendu E, Munoz F, Delmas PD, Chapurlat RD. The FRAX® tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort? J Bone Miner Res. 2010 Oct;25(10):2101-7. doi: 10.1002/jbmr.106</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Silverman SL, Calderon AD. The utility and limitations of FRAX®: A US perspective. Curr Osteoporos Rep. 2010 Dec;8(4):192-7. doi: 10.1007/s11914-010-0032-1</mixed-citation><mixed-citation xml:lang="en">Silverman SL, Calderon AD. The utility and limitations of FRAX®: A US perspective. Curr Osteoporos Rep. 2010 Dec;8(4):192-7. doi: 10.1007/s11914-010-0032-1</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Donaldson MG, Cawthon PM, Schousboe JT, et al; Study of Osteoporotic Fractures (SOF). Novel methods to evaluate fracture risk models. J Bone Miner Res. 2011;26(8):1767-73. doi: 10.1002/jbmr.371</mixed-citation><mixed-citation xml:lang="en">Donaldson MG, Cawthon PM, Schousboe JT, et al; Study of Osteoporotic Fractures (SOF). Novel methods to evaluate fracture risk models. J Bone Miner Res. 2011;26(8):1767-73. doi: 10.1002/jbmr.371</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Roux S, Cabana F, Carrier N, et al. The World Health Organization Fracture Risk Assessment Tool (FRAX®) underestimates incident and recurrent fractures in consecutive patients with fragility fractures. J Clin Endocrinol Metab. 2014 Jul;99(7):2400-8. doi: 10.1210/jc.2013-4507</mixed-citation><mixed-citation xml:lang="en">Roux S, Cabana F, Carrier N, et al. The World Health Organization Fracture Risk Assessment Tool (FRAX®) underestimates incident and recurrent fractures in consecutive patients with fragility fractures. J Clin Endocrinol Metab. 2014 Jul;99(7):2400-8. doi: 10.1210/jc.2013-4507</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Setty N, Leboff MS, Thornhill TS, et al. Underestimated fracture probability in patients with unilateral hip osteoarthritis as calculated by FRAX®. J Clin Densitom. 2011 Oct-Dec;14(4):447-52. doi: 10.1016/j.jocd.2011.06.001</mixed-citation><mixed-citation xml:lang="en">Setty N, Leboff MS, Thornhill TS, et al. Underestimated fracture probability in patients with unilateral hip osteoarthritis as calculated by FRAX®. J Clin Densitom. 2011 Oct-Dec;14(4):447-52. doi: 10.1016/j.jocd.2011.06.001</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
